Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Cai, Jian ^a   Lu, Shuai ^a   Yao, Zheng ^a   Deng, Ya Ping ^a   Zhang, Ling Di ^a   Yu, Jia Wen ^a   Ren, Guo Fei ^a   Shen, Fu Ming ^b   Jiang, Guo Jun ^a  

^a Zhejiang Xiaoshan Hospital   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Glibenclamide; Inflammation; Lipopolysaccharides; Myocardium injury

Indexed keywords

ADRENALIN; GLIBENCLAMIDE; GLUCOSE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIDIABETIC AGENT; LIPOPOLYSACCHARIDE;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HEART; HEART MUSCLE INJURY; HEART RATE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; MICROSCOPY; MOUSE; NICK END LABELING; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN BLOOD LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; HEART INJURIES; PATHOLOGY; SEPSIS;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENDOTOXEMIA; GLYBURIDE; HEART INJURIES; HYPOGLYCEMIC AGENTS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; SEPSIS;

EID: 84906838373     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0106-y     Document Type: Article

References (51)

1. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007, 35(5):1244-1250. 10.1097/01.CCM.0000261890.41311.E9, 17414736.
2. Jackson SK, Abate W, Parton J, Jones S, Harwood JL. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J Leukoc Biol 2008, 84(1):86-92. 10.1189/jlb.0907601, 18403647.
3. Lassenius MI, Pietilainen KH, Kaartinen K, Pussinen PJ, Syrjanen J, Forsblom C, Porsti I, Rissanen A, Kaprio J, Mustonen J, Groop PH, Lehto M. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011, 34(8):1809-1815. 10.2337/dc10-2197, 21636801.
4. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest 2006, 86(1):9-22. 10.1038/labinvest.3700366, 16357866.
5. Yang ZW, Chen JK, Ni M, Zhao T, Deng YP, Tao X, Jiang GJ, Shen FM. Role of Kir6.2 subunits of ATP-sensitive potassium channels in endotoxemia-induced cardiac dysfunction. Cardiovasc Diabetol 2013, 12:75. 10.1186/1475-2840-12-75, 23659427.
6. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29 Suppl 1:S43-S48.
7. Grant RW, Dixit VD. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front Immunol 2013, 4:50. 10.3389/fimmu.2013.00050, 23483669.
8. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis 2005, 40(4):628-631. 10.1086/427699, 15712091.
9. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005, 41(3):281-288. 10.1086/431587, 16007521.
10. Riddle MC. Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?. J Clin Endocrinol Metab 2003, 88(2):528-530. 10.1210/jc.2002-021971, 12574174.
11. Pompermayer K, Amaral FA, Fagundes CT, Vieira AT, Cunha FQ, Teixeira MM, Souza DG. Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury. Eur J Pharmacol 2007, 556(1-3):215-222. 10.1016/j.ejphar.2006.10.065, 17182029.
12. Schmid D, Svoboda M, Sorgner A, Moravcevic I, Thalhammer T, Chiba P, Moslinger T. Glibenclamide reduces proinflammatory cytokines in an ex vivo model of human endotoxinaemia under hypoxaemic conditions. Life Sci 2011, 89(19-20):725-734. 10.1016/j.lfs.2011.08.017, 21925514.
13. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, Lee WP, Hoffman HM, Dixit VM. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 2009, 187(1):61-70. 10.1083/jcb.200903124, 19805629.
14. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L, Whitfield J, Barchet W, Colonna M, Vandenabeele P, Bertin J, Coyle A, Grant EP, Akira S, Nu´ñez G. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006, 440(7081):233-236. 10.1038/nature04517, 16407888.
15. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26(4):433-443. 10.1016/j.immuni.2007.03.008, 17433728.
16. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006, 440(7081):228-232. 10.1038/nature04515, 16407890.
17. Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 2009, 227(1):95-105. 10.1111/j.1600-065X.2008.00730.x, 19120479.
18. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440(7081):237-241. 10.1038/nature04516, 16407889.
19. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 2008, 105(26):9035-9040. 10.1073/pnas.0803933105, 18577586.
20. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320(5876):674-677. 10.1126/science.1156995, 18403674.
21. Parihar MS, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004, 11(4):397-402. 10.1016/j.jocn.2003.09.008, 15080956.
22. Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N. Effect of Dianex, a herbal formulation on experimentally induced diabetes mellitus. Phytother Res 2005, 19(5):409-415. 10.1002/ptr.1570, 16106394.
23. Ahmadi S, Ebrahimi SS, Oryan S, Rafieenia F. Blockades of ATP-sensitive potassium channels and L-type calcium channels improve analgesic effect of morphine in alloxan-induced diabetic mice. Pathophysiology 2012, 19(3):171-177. 10.1016/j.pathophys.2012.04.007, 22743153.
24. Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 2007, 171(6):1753-1761. 10.2353/ajpath.2007.070316, 17991713.
25. Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 2007, 317(5838):675-678. 10.1126/science.1142953, 17673665.
26. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004, 10(11):1245-1250. 10.1038/nm1116, 15475963.
27. Heinonen SE, Merentie M, Hedman M, Makinen PI, Loponen E, Kholova I, Bosch F, Laakso M, Yla-Herttuala S. Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice. Cardiovasc Diabetol 2011, 10:59. 10.1186/1475-2840-10-59, 21718508.
28. Zhao X, Yang H, Jiang G, Ni M, Deng Y, Cai J, Li Z, Shen F, Tao X. Simvastatin attenuates radiation-induced tissue damage in mice. J Radiat Res 2014, 55(2):257-264. 10.1093/jrr/rrt115, 24105712.
29. Ling MY, Ma ZY, Wang YY, Qi J, Liu L, Li L, Zhang Y. Up-regulated ATP-sensitive potassium channels play a role in increased inflammation and plaque vulnerability in macrophages. Atherosclerosis 2013, 226(2):348-355. 10.1016/j.atherosclerosis.2012.11.016, 23218803.
30. Ishimaru K, Ueno H, Kagitani S, Takabayashi D, Takata M, Inoue H. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats. J Cardiovasc Pharmacol 2007, 50(2):187-194. 10.1097/FJC.0b013e318064f150, 17703135.
31. Miao X, Wang Y, Sun J, Sun W, Tan Y, Cai L, Zheng Y, Su G, Liu Q, Wang Y. Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2. Cardiovasc Diabetol 2013, 12:54. 10.1186/1475-2840-12-54, 23536959.
32. Da SJ, Santos-Silva MC, Cunha FQ, Assreuy J. The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. J Pharmacol Exp Ther 2002, 300(3):946-951. 10.1124/jpet.300.3.946.
33. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR. Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 2010, 148(2):444-452. 10.1016/j.surg.2010.03.010, 20434747.
34. Simon F, Fernandez R. Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J Hypertens 2009, 27(6):1202-1216. 10.1097/HJH.0b013e328329e31c, 19307985.
35. Ting C, Bansal V, Batal I, Mounayar M, Chabtini L, El AG, Azzi J. Impairment of immune systems in diabetes. Adv Exp Med Biol 2012, 771:62-75. 23393672.
36. Lukewich MK, Lomax AE. Endotoxemia enhances catecholamine secretion from male mouse adrenal chromaffin cells through an increase in Ca (2+) release from the endoplasmic reticulum. Endocrinology 2014, 155(1):180-192. 10.1210/en.2013-1623, 24169560.
37. O'Sullivan L, Cuffe JS, Paravicini TM, Campbell S, Dickinson H, Singh RR, Gezmish O, Black MJ, Moritz KM. Prenatal exposure to dexamethasone in the mouse alters cardiac growth patterns and increases pulse pressure in aged male offspring. PLoS One 2013, 8(7):e69149. 10.1371/journal.pone.0069149, 23935943.
38. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310. 10.1097/00003246-200107000-00002, 11445675.
39. Chhabra P, Brayman KL. Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med 2013, 2(5):328-336. 10.5966/sctm.2012-0116, 23572052.
40. Grishman EK, White PC, Savani RC. Toll-like receptors, the NLRP3 inflammasome, and interleukin-1beta in the development and progression of type 1 diabetes. Pediatr Res 2012, 71(6):626-632. 10.1038/pr.2012.24, 22337228.
41. Wen HL, Liang ZS, Zhang R, Yang K. Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc Diabetol 2013, 12:50. 10.1186/1475-2840-12-50, 23530831.
42. Bilim O, Takeishi Y, Kitahara T, Arimoto T, Niizeki T, Sasaki T, Goto K, Kubota I. Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus. Cardiovasc Diabetol 2008, 7:2. 10.1186/1475-2840-7-2, 18241357.
43. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977, 60(4):884-899. 893679.
44. Nunes S, Soares E, Fernandes J, Viana S, Carvalho E, Pereira FC, Reis F. Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker. Cardiovasc Diabetol 2013, 12:44. 10.1186/1475-2840-12-44, 23497124.
45. Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology 2004, 145(11):4934-4939. 10.1210/en.2004-0737, 15284196.
46. Becerra A, Echeverria C, Varela D, Sarmiento D, Armisen R, Nunez-Villena F, Montecinos M, Simon F. Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death. Cardiovasc Res 2011, 91(4):677-684. 10.1093/cvr/cvr135, 21565835.
47. Gerzanich V, Woo SK, Vennekens R, Tsymbalyuk O, Ivanova S, Ivanov A, Geng Z, Chen Z, Nilius B, Flockerzi V, Freichel M, Simard JM. De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med 2009, 15(2):185-191. 10.1038/nm.1899, 19169264.
48. Grand T, Demion M, Norez C, Mettey Y, Launay P, Becq F, Bois P, Guinamard R. 9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels. Br J Pharmacol 2008, 153(8):1697-1705. 10.1038/bjp.2008.38, 18297105.
49. Simard C, Salle L, Rouet R, Guinamard R. Transient receptor potential melastatin 4 inhibitor 9-phenanthrol abolishes arrhythmias induced by hypoxia and re-oxygenation in mouse ventricle. Br J Pharmacol 2012, 165(7):2354-2364. 10.1111/j.1476-5381.2011.01715.x, 22014185.
50. Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009, 29(2):317-330. 10.1038/jcbfm.2008.120, 18854840.
51. Koh GC, Weehuizen TA, Breitbach K, Krause K, de Jong HK, Kager LM, Hoogendijk AJ, Bast A, Peacock SJ, van der Poll T, Steinmetz I, Wiersinga WJ. Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis 2013, 7(10):e2500. 10.1371/journal.pntd.0002500, 24147174.